ENTXW
Entera Bio Ltd.
Key Financials
Revenue
$42000
↓ 76.8%
Operating Income
$-11529000
↓ 20.3%
Gross Profit
$0
↓ 100.0%
Net Income
$-11439000
↓ 19.9%
EPS (Diluted)
$0.25
0.0%
Total Liabilities
$2.9M
↑ 120.8%
Cash & Equivalents
$7.1M
↓ 17.9%
Shareholders' Equity
$13.1M
↑ 62.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| PRE 14A | 9/23/2026 | View on SEC |
| EFFECT | 8/28/2026 | View on SEC |
| 424B3 | 8/28/2026 | View on SEC |
| S-3 | 8/21/2026 | View on SEC |
| 3 | 8/21/2026 | View on SEC |
| 8-K | 8/18/2026 | View on SEC |
| D | 8/12/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ENTXW |
| Company Name | Entera Bio Ltd. |
| CIK | 1638097 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | L3 |
| Phone | 972-2-532-7151 |